Search research articles
Contact Us
Filters
Showing results (81-90 of 206) with videos related to
Page
of 21
Sort By:
Journal of the National Cancer Institute
|
February 1, 1973
Increased lifespan with altered sequence of administration of BCNU and cytoxan in L1210 leukemic mice
M J Straus, S C Choi, A Goldin
Cancer Treatment Reports
|
January 1, 1976
Activity of anthracyclines against an adriamycin (NSC-123127)-resistant subline of P388 leukemia with special emphasis on cinerubin A (NSC-18334)
R K Johnson, A A Ovejera, A Goldin
British Journal of Cancer
|
March 1, 1982
Characterization of a monoclonal antibody to L1210 leukaemia
C Testorelli, S Morelli, A Goldin, et al.
Cancer Research
|
January 1, 1976
Immunosensitivity and histocompatibility antigens in drug-altered leukemic cells
A Nicolin, P Franco, C Testorelli, et al.
Vestnik Khirurgii Imeni I. I. Grekova
|
March 29, 2003
[Using a compression method after surgical treatment of hemorrhoids]
V A Goldin, O A Dedenkov, M Alfazzaman
Proceedings of the National Academy of Sciences of the United States of America
|
August 1, 1970
Immunological alteration of leukemic cells in vivo after treatment with an antitumor drug
E Bonmassar, A Bonmassar, S Vadlamudi, et al.
Chemotherapy
|
January 1, 1970
Combination chemotherapy of mouse leukemia L 1210 with a neuroleptic and antimetabolites
V Pujman, J Sandberg, L Howsden, et al.
Cancer Research
|
June 1, 1970
Hematopoietic recovery after large doses of cyclophosphamide: correlation of proliferative state with sensitivity
W D DeWys, A Goldin, Man, et al.
Experientia
|
May 15, 1970
Primary antibody response in mice bearing leukemia L1210
E Bonmassar, A Bonmassar, S Vadlamudi, et al.
Nature
|
October 18, 1974
Cellular immune response to a drug-treated L5178Y lymphoma subline
A Nicolin, A Bini, E Coronetti, et al.
Page
of 21
Search research articles
Search
Showing results (81-90 of 206) with videos related to
Sort By:
Page
of 21
Journal of the National Cancer Institute
|
February 1, 1973
Increased lifespan with altered sequence of administration of BCNU and cytoxan in L1210 leukemic mice
M J Straus, S C Choi, A Goldin
Cancer Treatment Reports
|
January 1, 1976
Activity of anthracyclines against an adriamycin (NSC-123127)-resistant subline of P388 leukemia with special emphasis on cinerubin A (NSC-18334)
R K Johnson, A A Ovejera, A Goldin
British Journal of Cancer
|
March 1, 1982
Characterization of a monoclonal antibody to L1210 leukaemia
C Testorelli, S Morelli, A Goldin, et al.
Cancer Research
|
January 1, 1976
Immunosensitivity and histocompatibility antigens in drug-altered leukemic cells
A Nicolin, P Franco, C Testorelli, et al.
Vestnik Khirurgii Imeni I. I. Grekova
|
March 29, 2003
[Using a compression method after surgical treatment of hemorrhoids]
V A Goldin, O A Dedenkov, M Alfazzaman
Proceedings of the National Academy of Sciences of the United States of America
|
August 1, 1970
Immunological alteration of leukemic cells in vivo after treatment with an antitumor drug
E Bonmassar, A Bonmassar, S Vadlamudi, et al.
Chemotherapy
|
January 1, 1970
Combination chemotherapy of mouse leukemia L 1210 with a neuroleptic and antimetabolites
V Pujman, J Sandberg, L Howsden, et al.
Cancer Research
|
June 1, 1970
Hematopoietic recovery after large doses of cyclophosphamide: correlation of proliferative state with sensitivity
W D DeWys, A Goldin, Man, et al.
Experientia
|
May 15, 1970
Primary antibody response in mice bearing leukemia L1210
E Bonmassar, A Bonmassar, S Vadlamudi, et al.
Nature
|
October 18, 1974
Cellular immune response to a drug-treated L5178Y lymphoma subline
A Nicolin, A Bini, E Coronetti, et al.
Page
of 21